当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
オープンアクセスジャーナルはより多くの読者と引用を獲得 700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
研究論文
Age-Related Expression of Beta-Synuclein in the Ascending Visual Pathway and Comparative Analysis of its Function within the Neuroretina and Cerebral Cortex In-vitro
Occipital and Cingulate Hypometabolism are Significantly Under-Reported on 18-Fluorodeoxyglucose Positron Emission Tomography Scans of Patients with Lewy Body Dementia
コメント
Is Preservation of Cholinergic Activation a Mechanism Underlying Cognitive Reserve?
解説
Applications of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Parkinson's Disease
総説
Evolutionary Considerations on Aging and Alzheimer's Disease
Mild Cognitive Impairment: Implications of Diagnosis
The Receptor for Advanced Glycation Endproducts (RAGE) and Mediation of Inflammatory Neurodegeneration
microRNAs in Neurodegeneration: Current Findings and Potential Impacts
Radiation and Alzheimer's Disease (AD)
The Correlation between Genotype and Phenotype of Alzheimer's Disease
Does the Choice of Treatment of Diabetes Mellitus Change Natural Course of Alzheimer Disease?
Correlation between Metabolic Syndrome and Mild Cognitive Impairment
ミニレビュー
Risks and Triggers of Psychosis in Parkinson Disease
Towards a Circuit-Level Understanding of Hippocampal CA1 Dysfunction in Alzheimer's Disease Across Anatomical Axes
Analysis of Structure and Cost in an American Longitudinal Study of Alzheimer's Disease
Lifetime Expectancy in Dementia with Lewy Bodies: Effects of Donepezil Administration and Special Nursing Home Replacement. A Retrospective Analysis in the Tajiri Project
Effects of Plasmalogen on Patients with Mild Cognitive Impairment: A Randomized, Placebo-Controlled Trial in Japan